《新生儿牛奶蛋白过敏诊断与管理专家共识（2023）》要点解读

Interpretation of key points from the "Expert Consensus on Diagnosis and Management of Neonatal Cow Milk Protein Allergy (2023)"

摘要:

新生儿牛奶蛋白过敏（cow's milk protein allergy, CMPA）临床表现不典型，可导致多器官和系统受累，并且可能影响新生儿体格生长和中枢神经系统发育，造成机体功能障碍，还会增加其他家庭成员的焦虑和压力。由于缺乏特异性临床表现和诊断方法，新生儿CMPA的诊断和管理仍然是目前非常重要的临床挑战。为促进新生儿CMPA规范化诊治，由中华医学会儿科学分会新生儿学组、中华儿科杂志编辑委员会组织制定了《新生儿牛奶蛋白过敏诊断与管理专家共识（2023）》，该文对该共识新生儿CMPA饮食和营养管理部分重点内容进行介绍和解读。

Abstract:

The clinical manifestations of cow's milk protein allergy (CMPA) in neonates are non-specific and involve multiple organ systems. CMPA may also adversely affect physical growth and central nervous system development in neonates, lead to functional disorders, and increase anxiety and stress among family members. Due to the lack of specific clinical manifestations and diagnostic methods, the diagnosis and management of CMPA in neonates continue to pose significant clinical challenges. To facilitate standardized diagnosis and treatment of CMPA in neonates, the Neonatology Group of the Pediatric Branch of the Chinese Medical Association and the Editorial Committee of the Chinese Journal of Pediatrics have jointly developed the "Expert Consensus on Diagnosis and Management of Neonatal Cow's Milk Protein Allergy (2023)". This article presents and interprets the key points of the consensus regarding dietary and nutritional management of CMPA in neonates.